BoomRay and Novartis Pharma sign $900m deal for radioligand therapy
Pharmaceutical Business Review
Pharmaceutical Business Review
Latest news for Novartis, a global healthcare company based in Switzerland specialising in pharmaceuticals, including updates on company and product news.